RAPT Therapeutics (RAPT) Leases (2022 - 2024)
Historic Leases for Therapeutics (RAPT) over the last 3 years, with Q3 2024 value amounting to $3.8 million.
- Therapeutics' Leases fell 3256.35% to $3.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $3.8 million, marking a year-over-year decrease of 3256.35%. This contributed to the annual value of $5.2 million for FY2023, which is 2466.86% down from last year.
- As of Q3 2024, Therapeutics' Leases stood at $3.8 million, which was down 3256.35% from $4.3 million recorded in Q2 2024.
- In the past 5 years, Therapeutics' Leases ranged from a high of $6.9 million in Q4 2022 and a low of $3.8 million during Q3 2024
- Moreover, its 3-year median value for Leases was $5.8 million (2022), whereas its average is $5.6 million.
- Its Leases has fluctuated over the past 5 years, first skyrocketed by 322.68% in 2023, then plummeted by 3256.35% in 2024.
- Over the past 3 years, Therapeutics' Leases (Quarter) stood at $6.9 million in 2022, then fell by 24.67% to $5.2 million in 2023, then decreased by 26.84% to $3.8 million in 2024.
- Its last three reported values are $3.8 million in Q3 2024, $4.3 million for Q2 2024, and $4.8 million during Q1 2024.